SAB Biotherapeutics- Unit (1 Ordinary share & 1/2 Wrt) Other Current Assets

As of the most recent data (June 2026), BCYPU shows a other current assets of $3.5M. That compares with $3.6M in the prior-year period — down 3.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BCYPU's other current assets is now $3.5M (was $3.6M) — a 3.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether SAB Biotherapeutics- Unit (1 Ordinary share & 1/2 Wrt) is outperforming or lagging.

Tracking BCYPU's other current assets over time shows whether SAB Biotherapeutics- Unit (1 Ordinary share & 1/2 Wrt) is scaling, shrinking, or reshaping that part of the business. The current reading is $3.5M That compares with $3.6M in the prior-year period — down 3.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current assets page, Stockcircle has SAB Biotherapeutics- Unit (1 Ordinary share & 1/2 Wrt)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $3.5M) with ownership activity and broader fundamentals.